diabetes & metabolic syndrome

[1] Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers.

[2] o uso de inibidores da enzima conversora de angiotensina e sua relação com eventos no pós-operatório de cirurgia de revascularização miocárdica the use of inhibitors of angiotensin-converting enzyme and its relation to events in the postoperative period of cabg

[3] effect of renin-angiotensin system blockage in patients with acute respiratory distress syndrome: a retrospective case control study

[4] delayed angioedema during therapy with angiotensin-converting enzyme inhibitors

[5] Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction.

[6] angiotensin-converting enzyme inhibitors-induced angioedema of the small bowel mimicking postoperative complication

[7] angiotensin-converting enzyme inhibitors and receptor blockers in heart failure and chronic kidney disease – demystifying controversies

[8] delayed angioedema during therapy with angiotensin-converting enzyme inhibitors